CONCORD DRUGS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Concord Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
4.79₹ 3.2
As on Oct 31, 2025, 4:01 PM IST
Concord Drugs Price Performance
Today's LowToday's High
₹64.74₹70.00
₹70.00
52 Weeks' Low52 Weeks' High
₹26.10₹71.50
₹70.00
Open Price
₹64.74
Prev. Close
₹66.80
Volume
4,352
Over the last 5 years, the share price of Concord Drugs has gained 22.77% CAGR. Over the past year, the corresponding return has been 86.12%.
Concord Drugs’s current P/E of 164.32x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Concord Drugs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Concord Drugs | 4.65 | 2.90 | 22.55 | 133.72 | 86.12 | 31.98 | 22.77 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Concord Drugs has gained 86.12% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Concord Drugs has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Concord Drugs Financials
Concord Drugs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 66.07 | 66.72 |
| 10 | 65.5 | 66.39 |
| 20 | 66.48 | 66.2 |
| 50 | 63.96 | 63.65 |
| 100 | 55.92 | 57.59 |
| 200 | 44.47 | 50.06 |
Concord Drugs Share Holding Pattern
In the latest quarter, Concord Drugs remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 45.61% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Concord Drugs Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 14, 2025, 8:25 PM IST | Concord Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2025, 9:42 PM IST | Concord Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 30, 2025, 11:32 PM IST | Concord Drugs - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Sep 09, 2025, 9:46 PM IST | Concord Drugs - Reg. 34 (1) Annual Report. |
| Sep 09, 2025, 1:58 AM IST | Concord Drugs - Letter To Shareholders |
About Concord Drugs
Concord Drugs Ltd. is a Public Limited Listed company incorporated on 24/04/1995 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1995PLC020093 and registration number is 020093. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 36.93 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressSurvey No.249, R R District Telangana 501511
- Contact
Management
- Mr. S Nagi ReddyChairman & Managing Director
- Mr. S Manoj Kumar ReddyWhole Time Director
- Mr. S Koni ReddyWholeTime Director & CFO
- Mr. K Ramachandra ReddyIndependent Director
- Ms. Sumeela KasuIndependent Director
- Mr. S Nagavenkata HareeshIndependent Director
FAQs on Concord Drugs Share Price
What is the share price of Concord Drugs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Concord Drugs is ₹70.00 as on Oct 31, 2025.
What kind of stock is Concord Drugs?
The Concord Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Concord Drugs?
The market cap of Concord Drugs is ₹70.00 Cr as on Oct 31, 2025.
What are today's High and Low prices of Concord Drugs?
Today’s highest and lowest price of Concord Drugs are ₹70.00 and ₹64.74.
What are the 52 Week High and 52 Week Low of Concord Drugs?
The 52-week high/low is the highest and lowest price at which Concord Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Concord Drugs is ₹71.50 and 52-week low of Concord Drugs is ₹26.10 as on Oct 31, 2025.
How has the Concord Drugs performed historically in terms of returns?
The Concord Drugs has shown returns of 4.79% over the past day, 2.9% for the past month, 22.55% over 3 months, 86.12% over 1 year, 31.98% across 3 years, and 22.77% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Concord Drugs?
P/E ratio of and PB ratio of Concord Drugs are 164.32 and 2.07 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse